Sen Schumer asks FDA to place hold on Paxil for kids Fri, 13 Jun 2003 Senator Charles Schumer held a press conference in New York to announce that he had written to Mark McClellan, FDA Commissioner to investigate the adverse effects of Paxil, the SSRI antidepressant on children and teens,…
Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…
20% Drop in Psych Drugs Prescribed for US Children – WashPost Sat, 8 Oct 2005 The Washington Post reports (below) that prescriptions for antidepressants for children have dropped an unprecedented 20% in the US. A continuing series of substantiated reports and Black Box warnings about an increased risk of suicide,…
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
Congress & the White House must remedy a prescription for danger – LA Times / CBS News Thu, 1 Apr 2004 For those who missed the CBS evening News broadcast (Tues March 30) about FDA’s suppression of evidence, a video of that powerful report can be viewed online. http://www.cbsnews.com/stories/2004/03/30/eveningnews/main609491.shtml CBS…
Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to screen the entire United States population – children…
Data from Unpublished Trials Suggest that Most SSRI Antidepressant Drugs Unsuitable for Children Wed, 21 Apr 2004 An independent analysis in next week’s The Lancet compares the published and unpublished data of pediatric SSRI antidepressant clinical trial data, finding the published reports not to be evidence-based. “In a global medical…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
An Open Letter to Officials of the National Institute of Mental Health Fri, 30 Apr 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org From: Vera Hassner Sharav, President David Cohen, Ph.D. Secretary The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) To: Thomas Insell, MD,…
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm It airs momorrow.
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
The Washington Post reveals that a shocking secret investigative report by a Nigerian government panel of medical experts concluded that Pfizer Pharmaceuticals conducted an unethical drug experiment in Nigeria in 1996.
